Fast Facts: Managing Immune-related Adverse Events in Oncology : Early Recognition, Prompt Intervention, Effective Management

Immunotherapeutic products, and immune checkpoints inhibitors in particular, are increasingly used in the management of malignancies, both as monotherapies and in combination. Adverse events tend to be mild to moderate, but they can be severe or even life-threatening. Prompt recognition and effectiv...

Full description